Alyson Fox
Novartis Institutes for Biomedical Research
5 Gower Place
London WC1E 6BS
Name/email consistency: high
- Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor. Fox, A., Kaur, S., Li, B., Panesar, M., Saha, U., Davis, C., Dragoni, I., Colley, S., Ritchie, T., Bevan, S., Burgess, G., McIntyre, P. Br. J. Pharmacol. (2005)
- Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Fox, A., Medhurst, S., Courade, J.P., Glatt, M., Dawson, J., Urban, L., Bevan, S., Gonzalez, I. Pain (2004)
- Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Fox, A., Gentry, C., Patel, S., Kesingland, A., Bevan, S. Pain (2003)
- Airway nerves: in vitro electrophysiology. Fox, A. Curr. Opin. Pharmacol (2002)
- The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L., James, I. Pain (2001)
- Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Fox, A., Eastwood, C., Gentry, C., Manning, D., Urban, L. Pain (1999)
